z-logo
open-access-imgOpen Access
NR4A3 Mediates Thymic Negative Selection
Author(s) -
Salix Boulet,
Livia Odagiu,
Mengqi Dong,
MarieÈve Lebel,
JeanFrançois Daudelin,
Heather J. Melichar,
Nathalie Labrecque
Publication year - 2021
Publication title -
the journal of immunology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1901228
Subject(s) - selection (genetic algorithm) , negative selection , biology , psychology , computational biology , computer science , genetics , artificial intelligence , genome , gene
Central tolerance aims to limit the production of T lymphocytes bearing TCR with high affinity for self-peptide presented by MHC molecules. The accumulation of thymocytes with such receptors is limited by negative selection or by diversion into alternative differentiation, including T regulatory cell commitment. A role for the orphan nuclear receptor NR4A3 in negative selection has been suggested, but its function in this process has never been investigated. We find tha Nr4a3 ranscription is upregulated in postselection double-positive thymocytes, particularly those that have received a strong selecting signal and are destined for negative selection. Indeed, we found an accumulation of cells bearing a negative selection phenotype in NR4A3-deficient mice as compared with wild-type controls, suggesting tha Nr4a3 ranscriptional induction is necessary to limit accumulation of self-reactive thymocytes. This is consistent with a decrease of cleaved caspase-3 + -signaled thymocytes and more T regulatory and CD4 + Foxp3 - HELIOS + cells in the NR4A3-deficient thymus. We further tested the role for NR4A3 in negative selection by reconstituting transgenic mice expressing the OVA Ag under the control of the insulin promoter with bone marrow cells from OT-I Nr4a3 +/+ or OT-I Nr4a3 -/- mice. Accumulation of autoreactive CD8 thymocytes and autoimmune diabetes developed only in the absence of NR4A3. Overall, our results demonstrate an important role for NR4A3 in T cell development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom